Oregon Public Employees Retirement Fund Has $696,000 Stake in Prestige Consumer Healthcare Inc (NYSE:PBH)

Oregon Public Employees Retirement Fund trimmed its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 1.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,523 shares of the company’s stock after selling 300 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Prestige Consumer Healthcare were worth $696,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Huntington National Bank lifted its holdings in Prestige Consumer Healthcare by 45.4% during the 1st quarter. Huntington National Bank now owns 782 shares of the company’s stock worth $29,000 after purchasing an additional 244 shares during the last quarter. Advisor Group Holdings Inc. acquired a new stake in Prestige Consumer Healthcare during the 1st quarter worth approximately $62,000. Contravisory Investment Management Inc. acquired a new stake in Prestige Consumer Healthcare during the 2nd quarter worth approximately $156,000. Aigen Investment Management LP acquired a new stake in Prestige Consumer Healthcare during the 1st quarter worth approximately $165,000. Finally, Highlander Capital Management LLC acquired a new stake in Prestige Consumer Healthcare during the 1st quarter worth approximately $183,000.

In other news, CEO Ronald M. Lombardi sold 29,593 shares of Prestige Consumer Healthcare stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $40.00, for a total value of $1,183,720.00. Following the transaction, the chief executive officer now owns 154,630 shares in the company, valued at approximately $6,185,200. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.20% of the company’s stock.

Shares of NYSE PBH opened at $37.19 on Friday. The stock has a market capitalization of $1.87 billion, a PE ratio of 13.38, a P/E/G ratio of 3.14 and a beta of 0.80. The company has a debt-to-equity ratio of 1.50, a current ratio of 2.44 and a quick ratio of 1.67. The business has a fifty day moving average price of $38.20 and a two-hundred day moving average price of $39.22. Prestige Consumer Healthcare Inc has a fifty-two week low of $27.40 and a fifty-two week high of $46.12.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.74 by $0.08. Prestige Consumer Healthcare had a return on equity of 13.33% and a net margin of 14.77%. The company had revenue of $251.20 million for the quarter, compared to analyst estimates of $239.65 million. During the same quarter last year, the company posted $0.72 EPS. The company’s revenue for the quarter was up 4.2% compared to the same quarter last year. On average, equities analysts expect that Prestige Consumer Healthcare Inc will post 2.99 EPS for the current year.

Several analysts recently weighed in on the company. Oppenheimer reissued a “hold” rating on shares of Prestige Consumer Healthcare in a report on Wednesday, June 17th. TheStreet raised Prestige Consumer Healthcare from a “c” rating to a “b-” rating in a report on Thursday, May 7th. CIBC lifted their price target on Prestige Consumer Healthcare from $86.00 to $88.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. TD Securities lifted their price objective on Prestige Consumer Healthcare from $90.00 to $97.00 and gave the company a “hold” rating in a report on Friday, July 24th. Finally, ValuEngine cut Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, July 2nd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company. Prestige Consumer Healthcare has a consensus rating of “Hold” and a consensus target price of $65.43.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Further Reading: What are the benefits of a balanced fund?

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.